Alexander Tells FDA To Create ‘Red Team’ For Regulatory Streamlining

HELP Committee Chairman Lamar Alexander wants FDA to suggest regs and other bureaucratic requirements that are hindering productivity as part of medical innovation effort.

FDA might have a chance to eliminate some of the red tape that irritates staff and hinders productivity in the name of speeding new drugs to market.

As part of the Senate’s effort to move innovative medical products to patients faster, Sen. Lamar Alexander, R-Tenn., asked FDA...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America